Cart
sales@molnova.com
Zalcitabine
CAS No. 7481-89-2
Zalcitabine ( ddC;Dideoxycytidin )
Catalog No. M15852 CAS No. 7481-89-2
A pyrimidine analog reverse transcriptase inhibitor (NRTI) for the treatment of HIV/AIDS.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 27 | In Stock |
|
| 50MG | 39 | In Stock |
|
| 100MG | 55 | In Stock |
|
| 200MG | 73 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameZalcitabine
-
NoteResearch use only, not for human use.
-
Brief DescriptionA pyrimidine analog reverse transcriptase inhibitor (NRTI) for the treatment of HIV/AIDS.
-
DescriptionA pyrimidine analog reverse transcriptase inhibitor (NRTI) for the treatment of HIV/AIDS; also incorporates into the viral DNA, hence terminating the chain elongation due to the missing hydroxyl group; highly oral activity.HIV Infection Approved
-
SynonymsddC;Dideoxycytidin
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research AreaInfection
-
IndicationHIV Infection
Chemical Information
-
CAS Number7481-89-2
-
Formula Weight211.22
-
Molecular FormulaC9H13N3O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 16.67 mg/mL
-
SMILESO=C1N=C(N)C=CN1[C@@H]2O[C@H](CO)CC2
-
Chemical NameCytidine, 2',3'-dideoxy-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
DMJ-I-228
A small molecule CD4-mimetic that binds gp120 and blocks CD4 binding, inhibits HIV-1 entry with IC50 of 86.9 uM.
-
BMS-538203
A chemical intermidate of BMS-626529, a HIV-1 attachment inhibitor that targets gp120,
-
Punicalin
Punicalin exerts anti-inflammatory antioxidative and anti-hepatotoxic activities it shows inhibitory activity on HIV-1 reverse transcriptase in a dose-dependent manner with an IC50 of 0.11 microg/ml (0.14 microM).
